LXRX
Lexicon Pharmaceuticals Inc
Price:  
0.73 
USD
Volume:  
2,764,177.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX WACC - Weighted Average Cost of Capital

The WACC of Lexicon Pharmaceuticals Inc (LXRX) is 7.5%.

The Cost of Equity of Lexicon Pharmaceuticals Inc (LXRX) is 8.40%.
The Cost of Debt of Lexicon Pharmaceuticals Inc (LXRX) is 7.00%.

Range Selected
Cost of equity 6.30% - 10.50% 8.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.0% - 9.1% 7.5%
WACC

LXRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.52 1.01
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 10.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.36 0.36
Cost of debt 7.00% 7.00%
After-tax WACC 6.0% 9.1%
Selected WACC 7.5%